Thomas B. Neff

2017

In 2017, Thomas B. Neff earned a total compensation of $7.1M as Chief Executive Officer at FibroGen, a 35% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$693,000
Option Awards$2,850,751
Salary$840,000
Stock Awards$2,684,780
Other$20,160
Total$7,088,691

Neff received $2.9M in option awards, accounting for 40% of the total pay in 2017.

Neff also received $693K in non-equity incentive plan, $840K in salary, $2.7M in stock awards and $20.2K in other compensation.

Rankings

In 2017, Thomas B. Neff's compensation ranked 1,146th out of 14,666 executives tracked by ExecPay. In other words, Neff earned more than 92.2% of executives.

ClassificationRankingPercentile
All
1,146
out of 14,666
92nd
Division
Manufacturing
384
out of 5,768
93rd
Major group
Chemicals And Allied Products
102
out of 2,074
95th
Industry group
Drugs
69
out of 1,730
96th
Industry
Pharmaceutical Preparations
56
out of 1,329
96th
Source: SEC filing on April 24, 2018.

Neff's colleagues

We found two more compensation records of executives who worked with Thomas B. Neff at FibroGen in 2017.

2017

K Yu

FibroGen

Chief Medical Officer

2017

Pat Cotroneo

FibroGen

Chief Financial Officer

News

You may also like